HGWM
PRTK

Harvest Group Wealth Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Harvest Group Wealth Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$1K – 778
2020
Q4 		$1K Hold
100
– – ﹤0.01% 603
2020
Q3 		$1K Hold
100
– – ﹤0.01% 552
2020
Q2 		$0 Hold
100
– – ﹤0.01% 916
2020
Q1 		$0 Hold
100
– – ﹤0.01% 1106
2019
Q4 		$0 Hold
100
– – ﹤0.01% 1076
2019
Q3 		$0 Hold
100
– – ﹤0.01% 1153
2019
Q2 		$0 Hold
100
– – ﹤0.01% 1031
2019
Q1 		$1K Buy
+100
New +$646 ﹤0.01% 881

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harvest Group Wealth Management's PRTK Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2021, closing a stake of 100 shares — an estimated $1K sold.

Harvest Group Wealth Management first reported a position in PRTK in Q1 2019 and held it in 8 quarters. The position peaked at $1K in Q4 2020. 107 funds tracked by Wall St. Rank hold PRTK as of Q1 2021.

  • Harvest Group Wealth Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Harvest Group Wealth Management sold 100 Paratek Pharmaceuticals, Inc. shares in Q1 2021, an estimated $1K.
  • Harvest Group Wealth Management first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2019 and held it in 8 quarters.
  • Harvest Group Wealth Management's Paratek Pharmaceuticals, Inc. position peaked at $1K in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.